36
Participants
Start Date
January 31, 2006
Primary Completion Date
July 31, 2010
Patupilone/EPO906
Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science, San Antonio
South Texas Accelerated Research Therapeutics, San Antonio
University of California San Diego/Moores Cancer Center, La Jolla
Cancer Research and Treatment Center, Albuquerque
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY